When AI designs a drug, who gets the credit?

AI Earnings (Google News)en

When AI designs a drug, who gets the credit?

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by AI Earnings (Google News) — open it there to read it in full.

Read the full story at AI Earnings (Google News)

Related AI news